First Tracks Biotherapeutics, Inc. (TRAX) Sets Oct. 12 Release of ANB033 Phase 1b Cohort 1 Data

First Tracks Biotherapeutics will issue top-line data from Cohort 1 of its Phase 1b ANB033 celiac trial and host a webcast on Oct. 12, 2026, at 8:30am ET.Material DetailsContext by AI AnalystThis is an early clinical catalyst for ANB033 in celiac disease within a Phase 1b program. A positive effica…